EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)

$1.285 1.1237 (696.6522%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 71

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) News Sources

Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements

15-10-2025

yahoo.com

Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders

21-10-2025

yahoo.com

Eagle Pharmaceuticals Board Extends Limited Duration Stockholder Rights Plan

30-10-2025

yahoo.com

Eagle Pharmaceuticals Announces Divestiture of Barhemsys

14-01-2026

yahoo.com

EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) Sentiment Trend

0 25 50 75 100 76 60 61 87 15-10-2025 21-10-2025 30-10-2025 14-01-2026 #1 #2 #3 #4 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) FAQs

toggle

What is the current price of EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)?

The current price of EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) is $1.285.


toggle

EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) absolute price change since previous trading day?

The absolute price change of EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) since the previous trading day is $1.1237.


toggle

EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) percentage price change since previous trading day?

The percentage price change of EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) since the previous trading day is 696.6522%.


toggle

What is the most recent average sentiment score for EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)?

The most recent average sentiment score for EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) is 71 out of 100.


toggle

What is the most recent average sentiment for EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)?

The most recent sentiment for EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS) is .


SEC-8K** Filing Available For EAGLE PHARMACEUTICALS INC (EGRX:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.